Pharmacokinetics of rifabutin.

We investigated the pharmacokinetics of rifabutin in 15 male patients as part of a phase I trial of the treatment of early symptomatic human immunodeficiency virus infection. Six or more patients were studied at each of four different oral dosage levels: 300, 600, 900, and 1,200 mg/day. Twelve studi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Skinner, M H, Hsieh, M, Torseth, J, Pauloin, D, Bhatia, G, Harkonen, S, Merigan, T C, Blaschke, T F
Médium: Artigo
Jazyk:Inglês
Vydáno: 1989
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC172632/
https://ncbi.nlm.nih.gov/pubmed/2552902
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky